DANHOFER, Pavlína, Milan BRÁZDIL, Hana OŠLEJŠKOVÁ and Robert KUBA. Long-term seizure outcome in patients with juvenile absence epilepsy; a retrospective study in a tertiary referral center. Seizure-European journal of epilepsy. London: W.B. Saunders Ltd., 2014, vol. 23, No 6, p. 443-447. ISSN 1059-1311. Available from: https://dx.doi.org/10.1016/j.seizure.2014.03.002.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Long-term seizure outcome in patients with juvenile absence epilepsy; a retrospective study in a tertiary referral center
Authors DANHOFER, Pavlína (203 Czech Republic, guarantor, belonging to the institution), Milan BRÁZDIL (203 Czech Republic, belonging to the institution), Hana OŠLEJŠKOVÁ (203 Czech Republic, belonging to the institution) and Robert KUBA (203 Czech Republic, belonging to the institution).
Edition Seizure-European journal of epilepsy, London, W.B. Saunders Ltd. 2014, 1059-1311.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.822
RIV identification code RIV/00216224:14110/14:00075904
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.seizure.2014.03.002
UT WoS 000337997300007
Keywords in English Epilepsy; JAE; Juvenile absence epilepsy; Outcome; Seizure control; Therapy
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 24/10/2014 10:58.
Abstract
Purpose The study aim was to evaluate pharmacotherapy effects and long-term seizure outcomes in patients with juvenile absence epilepsy (JAE) during a five-year follow-up period. The secondary aim was to identify factors from patient history and determine their influence on seizure control. Method We retrospectively studied 46 patients with JAE in the period between 2006 and 2011. The age at seizure onset, onset seizure type, family history of epilepsy, status epilepticus in history, medication history, and the rate of seizure control were studied. Results There were 30 females (65.2%) and 16 males (34.8%) in the study. The mean age at seizure onset was 12.9 ± 5.6 years (ranged from 3 to 28 years). In 30 patients (65.2%), seizure onset was with absences, in 15 patients (32.6%) with generalized tonic-clonic seizure (GTCS), and in 1 patient (2.2%) with absence status. In 43 patients (93.5%), GTCS occurred in the course of the disease. Family history for epilepsy was positive in 10 patients (21.7%). In the five-year follow-up period, seizure freedom (Group 1) was achieved in 7 patients (15.2%). In total, 22 patients (47.8%) were classified into the groups involving very poor seizure control and antiepileptic drug resistance (Groups 5 and 6). The mean number of antiepileptic drugs (AEDs) used in the course of the disease in appropriate therapeutic doses was 3.8 ± 2.3 (1-10 AEDs). Conclusion The study results show that almost half of JAE patients have poor seizure control with a high rate of pharmacoresistance. The outcome of JAE can be very uncertain.
PrintDisplayed: 26/8/2024 02:37